{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:39:10Z","timestamp":1790959150100,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":36,"publisher":"Springer New York","isbn-type":[{"value":"9781493992195","type":"print"},{"value":"9781493992201","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-9220-1_22","type":"book-chapter","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T05:27:15Z","timestamp":1557984435000},"page":"303-328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Vaginal Suppositories with siRNA and Paclitaxel-Incorporated Solid Lipid Nanoparticles for Cervical Cancer: Preparation and In\u00a0Vitro Evaluation"],"prefix":"10.1007","author":[{"given":"G\u00fclay","family":"B\u00fcy\u00fckk\u00f6ro\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behiye","family":"\u015eenel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evrim","family":"Yenilmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"issue":"1","key":"22_CR1","first-page":"48","volume":"11","author":"M Urasa","year":"2011","unstructured":"Urasa M, Darj E (2011) Knowledge of cervical cancer and screening practices of nurses at a regional hospital in Tanzania. Afr Health Sci 11(1):48\u201357","journal-title":"Afr Health Sci"},{"key":"22_CR2","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1016\/j.febslet.2014.02.041","volume":"588","author":"V Volodko","year":"2014","unstructured":"Volodko V, Gordon M, Salla M, Ghazaleh HA, Baksh S (2014) RASSF tumor suppressor gene family: biological functions and regulation. FEBS Lett 588:2671\u20132684","journal-title":"FEBS Lett"},{"key":"22_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2007.07.016","volume":"123","author":"S Zhang","year":"2007","unstructured":"Zhang S, Zhao B, Jiang H, Wang B, Ma B (2007) Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release 123:1\u201310","journal-title":"J Control Release"},{"key":"22_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajps.2014.08.011","volume":"10","author":"C Xu","year":"2015","unstructured":"Xu C, Wang J (2015) Delivery systems for siRNA drug development in cancer therapy. Asian J Pharm Sci 10:1\u201312","journal-title":"Asian J Pharm Sci"},{"key":"22_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/35078107","volume":"411","author":"SM Elbashir","year":"2001","unstructured":"Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494\u2013498","journal-title":"Nature"},{"key":"22_CR6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.addr.2009.03.003","volume":"61","author":"YC Tseng","year":"2009","unstructured":"Tseng YC, Mozumdar S, Huang L (2009) Lipid-based systemic delivery of siRNA. Adv Drug Deliv Rev 61:721\u2013731","journal-title":"Adv Drug Deliv Rev"},{"issue":"18","key":"22_CR7","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.4161\/cc.5.18.3192","volume":"5","author":"CX Li","year":"2006","unstructured":"Li CX, Parker A, Menocal E, Xiang S, Borodyansky L, Fruehauf JH (2006) Delivery of RNA interference. Cell Cycle 5(18):2103\u20132109","journal-title":"Cell Cycle"},{"issue":"2","key":"22_CR8","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.bbrc.2007.08.189","volume":"363","author":"Y Takabatake","year":"2007","unstructured":"Takabatake Y, Isaka Y, Mizui M, Kawachi H, Takahara S, Imai E (2007) Chemically modified siRNA prolonged RNA interference in renal disease. Biochem Biophys Res Commun 363(2):432\u2013437","journal-title":"Biochem Biophys Res Commun"},{"key":"22_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jconrel.2007.05.021","volume":"121","author":"D Gary","year":"2007","unstructured":"Gary D, Puri N, Won YY (2007) Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. J Control Release 121:64\u201373","journal-title":"J Control Release"},{"issue":"1","key":"22_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.nano.2008.06.001","volume":"5","author":"D Reischl","year":"2009","unstructured":"Reischl D, Zimmer A (2009) Drug delivery of siRNA therapeutics: potentials and limits of nanosystems. Nanomed Nanotechnol Biol Med 5(1):8\u201320","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"9","key":"22_CR11","first-page":"1202","volume":"47","author":"M Gorbatyuk","year":"2007","unstructured":"Gorbatyuk M, Justilien V, Liu J, Hauswirth WW, Lewin AS (2007) Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery. VisionRes 47(9):1202\u20131208","journal-title":"VisionRes"},{"issue":"1","key":"22_CR12","first-page":"21","volume":"28","author":"GX Chen","year":"2006","unstructured":"Chen GX, Dong QH, Zhang JW, Fu FF, Xu ZF, Liang QY, Zheng S, Ding JY (2006) Knockdown of PLK1 mRNA by special siRNA. Yi Chuan 28(1):21\u201325","journal-title":"Yi Chuan"},{"issue":"4","key":"22_CR13","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.bbrc.2003.11.057","volume":"312","author":"M Sioud","year":"2003","unstructured":"Sioud M, S\u00f8rensen DR (2003) Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem Biophys Res Commun 312(4):1220\u20131225","journal-title":"Biochem Biophys Res Commun"},{"issue":"16","key":"22_CR14","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1021\/bi062138l","volume":"46","author":"NF Bouxsein","year":"2007","unstructured":"Bouxsein NF, Mcallister CS, Ewert KK, Samuel CE, Safinya RC (2007) Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA. Biochemistry 46(16):4785\u20134792","journal-title":"Biochemistry"},{"issue":"1","key":"22_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/nass\/49.1.17","volume":"49","author":"K Kataoka","year":"2005","unstructured":"Kataoka K, Itaka K, Nishiyama N, Yamasaki Y, Oishi M, Nagasaki Y (2005) Smart polymeric micelles as nanocarriers for oligonucleotides and siRNA delivery. Nucleic Acids Symp Ser 49(1):17\u201318","journal-title":"Nucleic Acids Symp Ser"},{"issue":"2","key":"22_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jconrel.2006.07.021","volume":"115","author":"H Katas","year":"2006","unstructured":"Katas H, Alpar HO (2006) Development and characterisation of chitosan nanoparticles for siRNA delivery. J Control Release 115(2):16\u201325","journal-title":"J Control Release"},{"key":"22_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1040-8428(03)00131-8","volume":"48","author":"A Savaese","year":"2003","unstructured":"Savaese A, Cognetti F (2003) New drugs in the treatment of recurrent or metastatic cervical cancer. Crit Rev Oncol Hematol 48:323\u2013327","journal-title":"Crit Rev Oncol Hematol"},{"key":"22_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ijpharm.2006.02.027","volume":"316","author":"J Wu","year":"2006","unstructured":"Wu J, Liu Q, Lee RJ (2006) A folate receptor-targeted liposomal formulation for paclitaxel. Int J Pharm 316:148\u2013153","journal-title":"Int J Pharm"},{"key":"22_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jconrel.2007.11.018","volume":"126","author":"TH Thu","year":"2008","unstructured":"Thu TH, Dass CR, Dunstan DE (2008) Injectable chitosan hydrogels for localized cancer therapy. J Control Release 126:205\u2013216","journal-title":"J Control Release"},{"issue":"3","key":"22_CR20","first-page":"405","volume":"3","author":"P Chimmiri","year":"2012","unstructured":"Chimmiri P, Rajalakshmi R, Mahitha B, Ramesh G, Noor Ahmed VH (2012) Solid lipid nanoparticles: a novel carrier for cancer therapy. Int J Pharm Biol Sci 3(3):405\u2013413","journal-title":"Int J Pharm Biol Sci"},{"key":"22_CR21","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.ejpb.2004.03.026","volume":"58","author":"L Serpea","year":"2004","unstructured":"Serpea L, Catalano MG, Cavalli R, Ugazio E, Bosco O, Canaparo R, Muntoni E, Frairia R, Gasco MR, Eandi M, Zara GP (2004) Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line. Eur J Pharm Biopharm 58:673\u2013680","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"22_CR22","first-page":"59","volume":"25","author":"R Shah","year":"2014","unstructured":"Shah R, Eldridge D, Palombo E, Harding I (2014) Optimisation and stability assessment of solid lipid nanoparticles using particle size and zeta potential. J Phys Sci 25(1):59\u201375","journal-title":"J Phys Sci"},{"key":"22_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.actbio.2016.04.026","volume":"38","author":"I Banerjee","year":"2016","unstructured":"Banerjee I, De K, Mukherjee D, Dey D, Chattopadhyay S, Mukherjee M, Mandal M, Bandyopadhyay AK, Gupta A, Ganguly S, Misra M (2016) Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced antiangiogenic and anti-glioma therapy. Acta Biomater 38:69\u201381","journal-title":"Acta Biomater"},{"key":"22_CR24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ejpb.2011.11.002","volume":"80","author":"YH Yu","year":"2012","unstructured":"Yu YH, Kim E, Park DE, Shim G, Lee S, Kim YB, Kim CW, Oha YK (2012) Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA. Eur J Pharm Biopharm 80:268\u2013273","journal-title":"Eur J Pharm Biopharm"},{"key":"22_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2005.03.032","volume":"106","author":"Z Paveli\u0107","year":"2005","unstructured":"Paveli\u0107 Z, Skalko-Basnet N, Filipovi\u0107-Grci\u0107 J, Martinac A, Jalsenjak I (2005) Development and in vitro evaluation of a liposomal vaginal delivery system for acyclovir. J Control Release 106:34\u201343","journal-title":"J Control Release"},{"key":"22_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jconrel.2004.11.034","volume":"103","author":"A Hussain","year":"2005","unstructured":"Hussain A, Ahsan F (2005) The vagina as a route for systemic drug delivery. J Control Release 103:301\u2013313","journal-title":"J Control Release"},{"key":"22_CR27","first-page":"3","volume":"10","author":"N Dobaria","year":"2007","unstructured":"Dobaria N, Mashru R, Vadia NH (2007) Vaginal drug delivery systems: a review of current status. East Cent Afr J Pharm Sci 10:3\u201313","journal-title":"East Cent Afr J Pharm Sci"},{"issue":"2","key":"22_CR28","first-page":"1033","volume":"3","author":"A Choudhury","year":"2011","unstructured":"Choudhury A, Das S, Kar M (2011) A review on novelty and potentiality of vaginal drug delivery. Int J PharmTech Res 3(2):1033\u20131044","journal-title":"Int J PharmTech Res"},{"key":"22_CR29","first-page":"190","volume-title":"Practical pharmaceutics: an international guideline for the preparation, care and use of medicinal products","author":"S Haas","year":"2015","unstructured":"Haas S, Woerdenbag H, Sznitowska M (2015) Rectal and vaginal. In: Bouwman-Boer Y, Fenton-May V, Brun PL (eds) Practical pharmaceutics: an international guideline for the preparation, care and use of medicinal products. Springer International Publishing AG, Cham, pp 190\u2013225"},{"key":"22_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ejpb.2016.10.017","volume":"109","author":"G B\u00fcy\u00fckk\u00f6ro\u011flu","year":"2016","unstructured":"B\u00fcy\u00fckk\u00f6ro\u011flu G, \u015eenel B, Ba\u015faran E, Yenilmez E, Yazan Y (2016) Preparation and in vitro evaluation of vaginal formulations including siRNA and paclitaxel-loaded SLNs for cervical cancer. Eur J Pharm Biopharm 109:174\u2013183","journal-title":"Eur J Pharm Biopharm"},{"key":"22_CR31","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3906\/kim-1412-40","volume":"39","author":"G B\u00fcy\u00fckk\u00f6ro\u011flu","year":"2015","unstructured":"B\u00fcy\u00fckk\u00f6ro\u011flu G, Yazan EY, \u00d6ner AF (2015) Preparation and physicochemical characterizations of solid lipid nanoparticles containing DOTAP\u00ae for DNA delivery. Turk J Chem 39:1012\u20131024","journal-title":"Turk J Chem"},{"key":"22_CR32","first-page":"379","volume":"85","author":"K Gvili","year":"2006","unstructured":"Gvili K, Benny O, Danino D, Machluf M (2006) Poly(D,L-lactide-coglycolide acid) nanoparticles for DNA delivery: waiving preparation complexity and increasing efficiency. Biopolymers 85:379\u2013391","journal-title":"Biopolymers"},{"issue":"2\u20133","key":"22_CR33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","volume":"47","author":"W Mehnert","year":"2001","unstructured":"Mehnert W, M\u00e4der K (2001) Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 47(2\u20133):165\u2013196","journal-title":"Adv Drug Deliv Rev"},{"key":"22_CR34","first-page":"698","volume":"8","author":"B \u015eenel","year":"2015","unstructured":"\u015eenel B, B\u00fcy\u00fckk\u00f6ro\u011flu G, Yazan Y (2015) Solid lipid and chitosan particulate systems for delivery of siRNA. Pharmazie 8:698\u2013705","journal-title":"Pharmazie"},{"key":"22_CR35","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ejpb.2007.12.007","volume":"69","author":"J Neves","year":"2008","unstructured":"Neves J, Amaral MH, Bahia MF (2008) Performance of an in vitro mucoadhesion testing method for vaginal semisolids: influence of different testing conditions and instrumental parameters. Eur J Pharm Biopharm 69:622\u2013632","journal-title":"Eur J Pharm Biopharm"},{"key":"22_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","volume":"59","author":"DH Owen","year":"1999","unstructured":"Owen DH, Katz DF (1999) A vaginal fluid simulant. Contraception 59:91\u201395","journal-title":"Contraception"}],"container-title":["Methods in Molecular Biology","RNA Interference and Cancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9220-1_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T16:40:51Z","timestamp":1558024851000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-9220-1_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493992195","9781493992201"],"references-count":36,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9220-1_22","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"17 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}